Add Company
Join Now

Rénibus Therapeutics Revenue and Competitors

License our Company Data API

Dallas, TX USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Rénibus Therapeutics's estimated annual revenue is currently $4.7M per year.(i)
  • Rénibus Therapeutics's estimated revenue per employee is $100,500

Employee Data

  • Rénibus Therapeutics has 47 Employees.(i)
  • Rénibus Therapeutics grew their employee count by 24% last year.

Rénibus Therapeutics's People

NameTitleEmail/Phone
1
Co-CEOReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
Chief Technical OfficerReveal Email/Phone
4
Chief Financial OfficerReveal Email/Phone
5
Chief Commercial OfficerReveal Email/Phone
6
VP, Market Access and ReimbursementReveal Email/Phone
7
VP Regulatory AffairsReveal Email/Phone
8
VP CommercialReveal Email/Phone
9
VP Clinical OperationsReveal Email/Phone
10
SVP, Program Management, Technical Operations and ManufacturingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$32.4M16120%N/AN/A
#2
$16.3M817%N/AN/A
#3
$18.7M9316%N/AN/A
#4
$62.5M0N/AN/AN/A
#5
$12.3M617%N/AN/A
#6
$3.2MN/A$22.2MN/A
#7
$184.1M91638%$50MN/A
#8
$27.7M1388%N/AN/A
#9
$112.4M5598%N/AN/A
#10
$12.5M6211%N/AN/A
Add Company

What Is Rénibus Therapeutics?

Rénibus Therapeutics is a clinical-stage biotech company dedicated to transforming the cardiorenal disease treatment paradigm by focusing on the prevention and treatment of kidney disease. The company’s portfolio includes RBT-1 for prevention of acute kidney injury, RBT-2 for treatment of chronic kidney disease, and RBT-3 for treatment of iron deficiency anemia and platinum-based kidney toxicity.

keywords:N/A

N/A

Total Funding

47

Number of Employees

$4.7M

Revenue (est)

24%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.5M47N/AN/A
#2
$12.2M4715%N/A
#3
$10.9M4734%N/A
#4
$10.6M490%N/A
#5
$10.6M499%N/A